Severe cholangitis following pancreaticoduodenectomy for pseudotumoral form of lymphoplasmacytic sclerosing pancreatitis

American Journal of Gastroenterology

Volumn 100, Issue 12, 2005, Pages 2808-2813

  Marrache, Frédéric ^a   Hammel, Pascal ^a,b   O'Toole, Dermot ^a   Cazals Hatem, Dominique ^b   Vullierme, Marie Pierre ^b   Sibert, Annie ^b   Ponsot, Philippe ^a   Maire, Frédérique ^a   Hentic, Olivia ^a   Sauvanet, Alain ^a   Lévy, Philippe ^a   Ruszniewski, Philippe ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT OBSTRUCTION; CASE REPORT; CHOLANGIOGRAPHY; CHOLANGITIS; CHOLEDOCHOJEJUNOSTOMY; CORTICOSTEROID THERAPY; FOLLOW UP; HUMAN; JAUNDICE; MALE; PANCREATICODUODENECTOMY; PANCREATITIS; PERCUTANEOUS TRANSHEPATIC DRAINAGE; PRIORITY JOURNAL; PSEUDOTUMOR; RELAPSE; STENT; ACUTE HEMORRHAGIC PANCREATITIS; BALLOON DILATATION; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEEDLE BIOPSY; PATHOLOGY; POSTOPERATIVE COMPLICATION; RADIOGRAPHY; RISK ASSESSMENT; SCLEROSING CHOLANGITIS; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGED; BALLOON DILATATION; BIOPSY, NEEDLE; CHOLANGIOGRAPHY; CHOLANGITIS, SCLEROSING; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; PANCREATITIS, ACUTE NECROTIZING; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33644816137     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00270.x     Document Type: Article

References (24)

1. Levy P Milan C Pignon JP, et al. Mortality factors associated with chronic pancreatitis. Unidimensional and multidimensional analysis of a medical-surgical series of 240 patients. Gastroenterology 1989 96 : 1165 72.
2. Sahani DV Kalva SP Farrell J, et al. Autoimmune pancreatitis: Imaging features. Radiology 2004 233 : 345 52.
3. Sarles H Sarles JC Muratore R, et al. Chronic inflammatory sclerosis of the pancreas - An autonomous pancreatic disease? Am J Dig Dis 1961 6 : 688 98.
4. Okazaki K. Clinical relevance of autoimmune-related pancreatitis. Best Pract Res Clin Gastroenterol 2002 16 : 365 78.
5. Kamisawa T Funata N Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003 52 : 683 7.
6. Uchida K Okazaki K Konishi Y, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 2000 95 : 2788 94.
7. Yoshida K Toki F Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995 40 : 1561 8.
8. 4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001 344 : 732 8.
9. Okazaki K Uchida K Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000 118 : 573 81.
10. Weber SM Cubukcu-Dimopulo O Palesty JA, et al. Lymphoplasmacytic sclerosing pancreatitis: Inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003 7 : 129 37.
11. Hardacre JM Iacobuzio-Donahue CA Sohn TA, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003 237 : 853 8.
12. Erkelens GW Vleggaar FP Lesterhuis W, et al. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999 354 : 43 4.
13. Horiuchi A Kawa S Hamano H, et al. Sclerosing pancreato-cholangitis responsive to corticosteroid therapy: Report of 2 case reports and review. Gastrointest Endosc 2001 53 : 518 22.
14. Nakazawa T Ohara H Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 2001 48 : 625 30.
15. Zamboni G Luttges J Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: A study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004 445 : 552 63.
16. Pearson RK Longnecker DS Chari ST, et al. Controversies in clinical pancreatology: Autoimmune pancreatitis: Does it exist? Pancreas 2003 27 : 1 13.
17. Kawaguchi K Koike M Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991 22 : 387 95.
18. Ectors N Maillet B Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997 41 : 263 8.
19. Nahon-Uzan K Lévy P O'Toole D, et al. Is idiopathic pancreatitis an autoimmune disease? Clin Gastroenterol Hepatol 2005 ( in press).
20. Terblanche J Allison HF Northover JM. An ischemic basis for biliary strictures. Surgery 1983 94 : 52 7.
21. Hirano K Shiratori Y Komatsu Y, et al. Involvement of the biliary system in autoimmune pancreatitis: A follow-up study. Clin Gastroenterol Hepatol 2003 1 : 453 64.
22. Tocchi A Mazzoni G Liotta G, et al. Management of benign biliary strictures: Biliary enteric anastomosis vs endoscopic stenting. Arch Surg 2000 135 : 153 7.
23. Draganov P Hoffman B Marsh W, et al. Long-term outcome in patients with benign biliary strictures treated endoscopically with multiple stents. Gastrointest Endosc 2002 55 : 680 6.
24. Farrell JJ Garber J Sahani D, et al. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004 60 : 927 36.